Results 11 to 20 of about 1,231,536 (373)

Eponyms in medical oncology

open access: yesCancer Treatment and Research Communications, 2022
Eponyms have historically been used to honor individual contributions or discoveries in the field of medicine. More recently, some eponyms have been criticized for imprecision or for being misnomers.
Priyanka Kumar   +3 more
doaj   +3 more sources

Second opinions in medical oncology [PDF]

open access: yesBMC Palliative Care, 2020
Background The current study aimed to further our understanding of second opinions among medical oncology patients by examining the proportion of patients who sought a second opinion about their cancer treatment, and why.
Ian Olver   +5 more
doaj   +5 more sources

Palliative medicine and medical oncology

open access: bronzeAnnals of Oncology, 2001
Traditionally, medical oncology and palliative care have been considered two distinct and separate disciplines, both as regards treatment objectives and delivery times. Palliative care in terminal stages, aimed exclusively at evaluating and improving quality of life, followed antitumor therapies, which concentrated solely on quantitative results (cure,
Marco Maltoni, D. Amadori
openalex   +5 more sources

CORAL: Expert-Curated medical Oncology Reports to Advance Language Model Inference [PDF]

open access: yes, 2023
Both medical care and observational studies in oncology require a thorough understanding of a patient's disease progression and treatment history, often elaborately documented in clinical notes. Despite their vital role, no current oncology information representation and annotation schema fully encapsulates the diversity of information recorded within ...
arxiv   +1 more source

Oncology education in Brazilian medical schools

open access: yesBrazilian Journal of Oncology, 2020
Background and Objective: Cancer is expected to be the leading cause of death in Brazil by 2030. This scenario demands that health professionals, especially physicians, should be able to implement primary prevention, early detection and cancer
Angelica Nogueira-Rodrigues   +14 more
doaj   +1 more source

Radiomics Study for Differentiating Focal Hepatic Lesions Based on Unenhanced CT Images

open access: yesFrontiers in Oncology, 2022
ObjectivesTo investigate the feasibility of computer-aided discriminative diagnosis among hepatocellular carcinoma (HCC), hepatic metastasis, hepatic hemangioma, hepatic cysts, hepatic adenoma, and hepatic focal nodular hyperplasia, based on radiomics ...
Xitong Zhao   +4 more
doaj   +1 more source

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis. [PDF]

open access: yes, 2021
BACKGROUND: Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other ...
Alvi, Raza M   +39 more
core   +1 more source

The importance of continual education in the process of integration of young nurses [PDF]

open access: yesArchive of Oncology, 2003
Background: Duty of a nurse-manager is to realize importance of integration of newly employed nurse for forming coherent, unique and efficacious team. Integration of newly employed nurses, especially those without working experience, includes acceptance ...
Delić Svetlana   +2 more
doaj   +1 more source

Radiation Oncology and Medical Physics [PDF]

open access: yesBioMed Research International, 2015
Radiation therapy has been evolving with technological advances in accelerator, computer, and imaging. As the planning target volumes (PTVs) are made increasingly conformal with the advent of three-dimensional conformal therapy (3D CRT) and intensity-modulated radiation therapy (IMRT), the requirements of precise PTVs localization and its dosimetric ...
Tsair-Fwu Lee   +5 more
openaire   +2 more sources

Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy. [PDF]

open access: yes, 2022
Trastuzumab is a mainstay chemotherapeutic agent used in the treatment of human epidermal growth factor receptor 2 (HER2)/neu-positive breast cancer that, though generally well-tolerated, is classically associated with side effects like cardiotoxicity ...
Chase, Ramona E, CRNP   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy